Found 14 matching trials
Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors PHASE4 Inhibition of dipeptidyl peptidase-4 (DPP-4) or sodium-glucose co-transport...
Show More Location
Kurume University Hospital
Learn More & Join Trial
Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy PHASE4 Study Hypothesis:Compared with premixed insulin, triple oral combination th...
Show More Location
The Pearl River Hospital of Southern Medical University
Learn More & Join Trial
Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2. PHASE2 A phase IV, randomized, double-blind, single center pilot study in subjects...
Show More Location
Department of Endocrinology and Metabolism, University of Pisa
Learn More & Join Trial
Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes PHASE3 In this study, the investigators will assess the efficacy and tolerability ...
Show More Location
Korea University Anam Hospital
Learn More & Join Trial
Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants PHASE1 The purpose of this study is to evaluate whether the pharmacokinetics (body...
Show More Location
Icon Clinical Pharmacology
Learn More & Join Trial
Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes Mellitus PHASE4 The Investigator hypothesize that Dapagliflozin will improve EPC number and...
Show More Location
The GW Medical Faculty Associates
Learn More & Join Trial
A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration. PHASE1 A Study to Assess the Fed-state Bioequivalence of a Triple Fixed-Combinatio...
Show More Learn More & Join Trial
Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes PHASE3 The purpose of this study is to learn if a combination of BMS-477118 (Saxag...
Show More Location
Central Alabama Research
Learn More & Join Trial
ESR-15-11293 - Saxa/Dapa, Safety and Efficacy Study NA This is a 16-week, single center, randomized, double-blind, active-controll...
Show More Location
The University of Texas Health Science Center at San Antonio
Learn More & Join Trial
A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin PHASE3 This research study of subjects with inadequately controlled type 2 diabete...
Show More Learn More & Join Trial